Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.

Adelson MO, Novick DM, Khuri E, Albeck H, Hahn EF, Kreek MJ.

Isr J Med Sci. 1994 Sep;30(9):679-84.

PMID:
8088979
2.

Naloxone benzoylhydrazone (NalBzoH) analgesia.

Paul D, Levison JA, Howard DH, Pick CG, Hahn EF, Pasternak GW.

J Pharmacol Exp Ther. 1990 Nov;255(2):769-74.

PMID:
2173757
3.

Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.

Schinazi RF, Sommadossi JP, Saalmann V, Cannon DL, Xie MY, Hart GC, Smith GA, Hahn EF.

Antimicrob Agents Chemother. 1990 Jun;34(6):1061-7.

4.

Opiate antagonists and anti-HIV agents.

Hahn EF.

NIDA Res Monogr. 1990;96:80-99. Review. No abstract available.

PMID:
2233999
5.

Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.

Gistrak MA, Paul D, Hahn EF, Pasternak GW.

J Pharmacol Exp Ther. 1989 Nov;251(2):469-76.

PMID:
2553921
6.

Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.

Price M, Gistrak MA, Itzhak Y, Hahn EF, Pasternak GW.

Mol Pharmacol. 1989 Jan;35(1):67-74.

PMID:
2536470
7.

Nucleotide dimers suppress HIV expression in vitro.

Busso M, Mian AM, Hahn EF, Resnick L.

AIDS Res Hum Retroviruses. 1988 Dec;4(6):449-55.

PMID:
2464362
8.

Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintainance of body weight in rats.

Mann PE, Pasternak GW, Hahn EF, Curreri G, Lubin E, Bodnar RJ.

Neuropharmacology. 1988 Apr;27(4):349-55.

PMID:
3419536
9.

Irreversible opiate agonists and antagonists. IV. Analgesic actions of 14-hydroxydihydromorphinone hydrazones.

Williams CL, Bodnar RJ, Clark JE, Hahn EF, Burks TF, Pasternak GW.

J Pharmacol Exp Ther. 1988 Apr;245(1):8-12.

PMID:
2452249
10.

Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine.

Mann PE, Arjune D, Romero MT, Pasternak GW, Hahn EF, Bodnar RJ.

Psychopharmacology (Berl). 1988;94(3):336-41.

PMID:
2895939
11.

Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone.

Luke MC, Hahn EF, Price M, Pasternak GW.

Life Sci. 1988;43(15):1249-56.

PMID:
2845215
12.

19-Hydroxylation and aromatization of androgens in the developing rat brain.

Michnovicz JJ, Hahn EF, Fishman J.

Endocrinology. 1987 Oct;121(4):1209-14.

PMID:
3653024
13.

The nature of the final oxidative step in the aromatization sequence.

Fishman J, Hahn EF.

Steroids. 1987 Oct-Dec;50(4-6):339-45. Review. No abstract available.

PMID:
3332932
14.

Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonist.

Galetta S, Hahn EF, Nishimura S, Pasternak GW.

Life Sci. 1987 Aug 10;41(6):783-7.

PMID:
2441221
15.

X-ray crystal structure of the opioid ligand naltrexonazine.

Urbanczyk-Lipkowska Z, Lipkowski AW, Etter MC, Hahn EF, Pasternak GW, Portoghese PS.

J Med Chem. 1987 Aug;30(8):1489-94.

PMID:
3039139
16.

Absence of reactive intermediates in the formation of catechol estrogens by rat liver microsomes.

Jellinck PH, Hahn EF, Fishman J.

J Biol Chem. 1986 Jun 15;261(17):7729-32.

17.
18.

Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.

Hahn EF, Itzhak Y, Nishimura S, Johnson N, Pasternak GW.

J Pharmacol Exp Ther. 1985 Dec;235(3):846-50.

PMID:
2416910
19.

Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.

Hahn EF, Nishimura S, Goodman RR, Pasternak GW.

J Pharmacol Exp Ther. 1985 Dec;235(3):839-45.

PMID:
2416909
20.

Castration affects male rat brain opiate receptor content.

Hahn EF, Fishman J.

Neuroendocrinology. 1985 Jul;41(1):60-3.

PMID:
2991795
21.

Testing and evaluation of opiate analgesics and antagonists.

Hahn EF.

Methods Find Exp Clin Pharmacol. 1985 Jul;7(7):373-81.

PMID:
2865415
22.

Stereochemistry of 1,2-hydrogen loss during aromatization in the brain.

Hahn EF, Fishman J.

J Steroid Biochem. 1985 May;22(5):597-600.

PMID:
4010285
23.

19-Hydroxylation of androgens in the rat brain.

Hahn EF, Miyairi S, Fishman J.

Proc Natl Acad Sci U S A. 1985 May;82(9):2728-30.

24.

The role of brain metabolism in the action of opiates.

Hahn EF.

Med Res Rev. 1985 Apr-Jun;5(2):255-72. Review. No abstract available.

PMID:
3887067
25.
26.

Chronic naloxone increases opiate binding in SHR and WKY rats.

Hahn EF.

Neurochem Res. 1984 Dec;9(12):1749-56.

PMID:
6099471
27.
28.

Interaction of naloxone and sodium chloride intake on body weight gain in WKY and SHR rats.

Hahn EF.

Res Commun Chem Pathol Pharmacol. 1984 Jun;44(3):339-45.

PMID:
6463362
30.

Naloxone radioimmunoassay: an improved antiserum.

Hahn EF, Lahita R, Kreek MJ, Duma C, Inturrisi CE.

J Pharm Pharmacol. 1983 Dec;35(12):833-6. No abstract available.

PMID:
6141253
31.

Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation.

Kreek MJ, Schaefer RA, Hahn EF, Fishman J.

Lancet. 1983 Feb 5;1(8319):261-2.

PMID:
6130292
32.

Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites.

Hahn EF, Pasternak GW.

Life Sci. 1982 Sep 20-27;31(12-13):1385-8.

PMID:
6292633
33.

Early exposure to naloxone increases blood pressure in normotensive and hypertensive rats.

Hahn EF, Martucci CP, Gilligan JP, Spector S.

Biochem Biophys Res Commun. 1982 Jul 30;107(2):707-13. No abstract available.

PMID:
7126236
34.

Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines.

Hahn EF, Carroll-Buatti M, Pasternak GW.

J Neurosci. 1982 May;2(5):572-6.

35.

Changes in brain N-demethylation and opiate receptor content correlate with analgesic effectiveness of morphine.

Hahn EF, Fishman J.

Res Commun Chem Pathol Pharmacol. 1980 Jul;29(1):197-200.

PMID:
6250207
36.

Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones.

Pasternak GW, Hahn EF.

J Med Chem. 1980 Jun;23(6):674-6.

PMID:
6156240
37.
38.

Changes in rat brain opiate receptor content upon castration and testosterone replacement.

Hahn EF, Fishman J.

Biochem Biophys Res Commun. 1979 Oct 12;90(3):819-23. No abstract available.

PMID:
228671
39.

Opiate target site N-demethylase enzymes: differences from the liver N-demethylase.

Hahn EF, Norton BI, Fishman J.

Biochem Biophys Res Commun. 1979 Jul 12;89(1):233-9. No abstract available.

PMID:
475809
40.

High sensitivity solid phase exchange radioimmunoassay for morphine.

Hahn EF, Fishman JH, Fishman J.

J Pharm Pharmacol. 1979 Apr;31(4):250-2. No abstract available.

PMID:
36467
41.
42.

Morphine metabolism in opiate dependent and normal men by double isotope techniques.

Hahn EF, Roffwarg H, Fishman J.

Res Commun Chem Pathol Pharmacol. 1977 Nov;18(3):401-14.

PMID:
928943
43.

The agonist and antagonist properties of N-allylenkephalins.

Hahn EF, Fishman J, Shiwaku Y, Foldes FF, Nagashima H, Duncalf D.

Res Commun Chem Pathol Pharmacol. 1977 Sep;18(1):1-9.

PMID:
198860
44.

Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series.

Ronai AZ, Foldes FF, Hahn EF, Fishman J.

J Pharmacol Exp Ther. 1977 Mar;200(3):496-500.

PMID:
66306
45.

Influence of gender and castration on liver and CNS N-demethylation of morphine in rats.

Hahn EF, Norton BI, Fishman J.

Life Sci. 1977 Jan 1;20(1):95-9. No abstract available.

PMID:
834113
46.

N-demethylation of morphine in rat brain is localised in sites with high opiate receptor content.

Fishman J, Hahn EF, Norton BI.

Nature. 1976 May 6;261(5555):64-5. No abstract available.

PMID:
1272376
47.

An evaluation of the hot plate technique to study narcotic antagonists.

Heilman RD, Gray MI, Chen RP, Hahn EF, Fishman J.

Res Commun Chem Pathol Pharmacol. 1976 Apr;13(4):635-47.

PMID:
1265343
48.

Dose related changes in tissue morphine concentration.

Hahn EF, Norton BI, Fishman J.

Res Commun Chem Pathol Pharmacol. 1976 Apr;13(4):569-77.

PMID:
1265337
49.

Comparative in vivo distribution of opiate agonists and antagonists by means of double isotope techniques.

Fishman J, Hahn EF, Norton BI.

Life Sci. 1975 Oct 10;17(7):1119-25. No abstract available.

PMID:
1196002
50.

Narcotic antagonists. 4. Carbon-6 derivatives of N-substituted noroxymorphones as narcotic antagonists.

Heilman RD, Hahn EF, Fishman J.

J Med Chem. 1975 Mar;18(3):259-62.

PMID:
1133815

Supplemental Content

Support Center